Lumos Diagnostics Holdings Limited (LDX.AX)

AUD 0.04

(5.88%)

Long Term Debt Summary of Lumos Diagnostics Holdings Limited

  • Lumos Diagnostics Holdings Limited's latest annual long term debt in 2024 was - USD , down 0.0% from previous year.
  • Lumos Diagnostics Holdings Limited's latest quarterly long term debt in 2024 Q3 was - USD , down 0.0% from previous quarter.
  • Lumos Diagnostics Holdings Limited reported annual long term debt of 7.74 Million USD in 2023, up 24.43% from previous year.
  • Lumos Diagnostics Holdings Limited reported annual long term debt of 6.22 Million USD in 2022, down -13.49% from previous year.
  • Lumos Diagnostics Holdings Limited reported quarterly long term debt of 7.62 Million USD for 2024 Q2, down 0.0% from previous quarter.
  • Lumos Diagnostics Holdings Limited reported quarterly long term debt of - USD for 2024 Q3, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Lumos Diagnostics Holdings Limited (2024 - 2018)

Historical Annual Long Term Debt of Lumos Diagnostics Holdings Limited (2024 - 2018)

Year Long Term Debt Long Term Debt Growth
2024 - USD 0.0%
2023 7.74 Million USD 24.43%
2022 6.22 Million USD -13.49%
2021 7.19 Million USD 121.88%
2020 3.24 Million USD -68.88%
2019 10.42 Million USD 0.0%
2018 - USD 0.0%

Peer Long Term Debt Comparison of Lumos Diagnostics Holdings Limited

Name Long Term Debt Long Term Debt Difference
Australian Clinical Labs Limited 55.06 Million AUD 100.0%
BCAL Diagnostics Limited 400.22 Thousand AUD 100.0%
Genetic Signatures Limited - AUD NaN%
Genetic Technologies Limited - AUD NaN%
Healius Limited 420.8 Million AUD 100.0%
Imagion Biosystems Limited 750 Thousand AUD 100.0%
Integral Diagnostics Limited 219.75 Million AUD 100.0%
INOVIQ Ltd - AUD NaN%
Microba Life Sciences Limited - AUD NaN%
Monash IVF Group Limited 59.56 Million AUD 100.0%
Rhythm Biosciences Limited - AUD NaN%
Sonic Healthcare Limited 2.69 Billion AUD 100.0%